Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
SARS‐CoV‐2 is a novel human coronavirus responsible for the Coronavirus disease 2019
(COVID‐19) pandemic. Pneumonia and acute respiratory distress syndrome are the major …
(COVID‐19) pandemic. Pneumonia and acute respiratory distress syndrome are the major …
COVID-19: immunopathology and its implications for therapy
X Cao - Nature reviews immunology, 2020 - nature.com
Severe coronavirus disease 2019 (COVID-19) is characterized by pneumonia, lymphopenia,
exhausted lymphocytes and a cytokine storm. Significant antibody production is observed; …
exhausted lymphocytes and a cytokine storm. Significant antibody production is observed; …
COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
COVID‐19 immunopathology: from acute diseases to chronic sequelae
The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …
as a primary affected organ, which is also a critical site of immune cell activation by severe …
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
LE van Eijk, M Binkhorst, AR Bourgonje… - The Journal of …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
T cell immunobiology and cytokine storm of COVID‐19
XH Luo, Y Zhu, J Mao, RC Du - Scandinavian journal of …, 2021 - Wiley Online Library
Abstract 2019 coronavirus disease (COVID‐19) presents as a newly recognized pneumonia
and could rapidly progress into acute respiratory distress syndrome which has brought …
and could rapidly progress into acute respiratory distress syndrome which has brought …
Immunity and inflammatory biomarkers in COVID‐19: a systematic review
APD Iwamura, MR Tavares da Silva… - Reviews in Medical …, 2021 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) is a clinical syndrome caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …
[HTML][HTML] CoViD-19 immunopathology and immunotherapy
F Chiappelli, A Khakshooy, G Greenberg - Bioinformation, 2020 - ncbi.nlm.nih.gov
New evidence on the T-cell immuno-pathology in patient's with Corona Virus Disease 2019
(CoViD-19) was reported by Diao et al. in MedRxiv (doi: 10.1101/2020.02. 18.20024364)[1] …
(CoViD-19) was reported by Diao et al. in MedRxiv (doi: 10.1101/2020.02. 18.20024364)[1] …